Drug Profile
Research programme: chemotherapy drug delivery system - BioLineRx
Alternative Names: BL-4010Latest Information Update: 24 Apr 2014
Price :
$50
*
At a glance
- Originator PolyGene
- Developer BioLineRx
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Solid tumours
Most Recent Events
- 24 Apr 2014 No development reported - Preclinical for Solid tumours in Israel (Intratumoural)
- 16 Feb 2009 Preclinical development is ongoing in Israel
- 14 Mar 2007 Preclinical trials in Solid tumours in Israel (Intratumoural)